$16.74
1.93% day before yesterday
NYSE, Dec 27, 10:00 pm CET
ISIN
NL0000200384
Symbol
CLB

Core Laboratories NV Stock price

$16.74
-3.67 17.98% 1M
-3.03 15.33% 6M
-0.92 5.21% YTD
-1.86 10.00% 1Y
-6.71 28.61% 3Y
-30.18 64.32% 5Y
-107.33 86.51% 10Y
NYSE, Closing price Fri, Dec 27 2024
-0.33 1.93%
ISIN
NL0000200384
Symbol
CLB
Sector

Key metrics

Market capitalization $785.94m
Enterprise Value $965.18m
P/E (TTM) P/E ratio 25.77
EV/FCF (TTM) EV/FCF 21.92
EV/Sales (TTM) EV/Sales 1.85
P/S ratio (TTM) P/S ratio 1.50
P/B ratio (TTM) P/B ratio 3.13
Dividend yield 0.24%
Last dividend (FY24) $0.04
Revenue growth (TTM) Revenue growth 2.68%
Revenue (TTM) Revenue $522.82m
EBIT (operating result TTM) EBIT $52.46m
Free Cash Flow (TTM) Free Cash Flow $44.04m
Cash position $21.47m
EPS (TTM) EPS $0.65
P/E forward 20.05
P/S forward 1.49
EV/Sales forward 1.83
Short interest 26.80%
Show more

Is Core Laboratories NV a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Core Laboratories NV Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Core Laboratories NV forecast:

1x Buy
14%
3x Hold
43%
3x Sell
43%

Analyst Opinions

7 Analysts have issued a Core Laboratories NV forecast:

Buy
14%
Hold
43%
Sell
43%

Financial data from Core Laboratories NV

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
523 523
3% 3%
100%
- Direct Costs 431 431
4% 4%
82%
92 92
3% 3%
18%
- Selling and Administrative Expenses 24 24
1% 1%
5%
- Research and Development Expense - -
-
-
68 68
6% 6%
13%
- Depreciation and Amortization 15 15
5% 5%
3%
EBIT (Operating Income) EBIT 52 52
6% 6%
10%
Net Profit 30 30
26% 26%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Core Laboratories NV directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Core Laboratories NV Stock News

Neutral
GlobeNewsWire
11 days ago
Dublin, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The "Clinical Chemistry and Immunoassay Industry, Global, 2023-2028" report has been added to ResearchAndMarkets.com's offering. This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine,...
Neutral
Seeking Alpha
2 months ago
Core Laboratories Inc. (NYSE:CLB ) Q3 2024 Earnings Conference Call October 24, 2024 8:30 AM ET Company Participants Larry Bruno - Chairman and Chief Executive Officer Chris Hill - Chief Financial Officer Gwen Gresham - Senior Vice President and Head, Investor Relations Conference Call Participants Sean Mitchell - Daniel Energy Partners Stephen Gengaro - Stifel Operator Good day and welcome to ...
Neutral
PRNewsWire
2 months ago
THIRD QUARTER REVENUE OF $134.4 MILLION, UP 3% SEQUENTIALLY AND OVER 7% YEAR-OVER-YEAR THIRD QUARTER OPERATING INCOME OF $19.8 MILLION; EX-ITEMS, $18.2 MILLION, UP 11% SEQUENTIALLY AND 14% YEAR-OVER-YEAR THIRD QUARTER OPERATING MARGINS, EX-ITEMS, OF 14% UP 100 BPS SEQUENTIALLY THIRD QUARTER GAAP EPS OF $0.25; EX-ITEMS, $0.25, UP 14% SEQUENTIALLY AND YEAR-OVER-YEAR THIRD QUARTER FREE CASH FLOW O...
More Core Laboratories NV News

Company Profile

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the following business segments: Reservoir Description and Production Enhancement. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.

Head office Netherlands
CEO Lawrence Bruno
Employees 3,600
Founded 2012
Website www.corelab.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today